Analysis of Geographic Areas
Vertex Pharmaceuticals Inc. operates in 2 regions: United States and Outside of the United States.
Area Asset Turnover
Vertex Pharmaceuticals Inc., asset turnover by geographic area
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 4.44 | 4.17 | 3.92 | 4.00 | 3.98 |
| Outside of the United States | 41.08 | 35.79 | 29.96 | 18.03 | 17.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
| Outside of the United States | Outside of the United States area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
Area Asset Turnover: United States
Vertex Pharmaceuticals Inc.; United States; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Revenues | 6,040,400) | 5,699,300) | 5,288,300) | 4,829,282) | 3,062,555) |
| Long-lived assets | 1,359,700) | 1,365,500) | 1,348,100) | 1,207,748) | 768,572) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 4.44 | 4.17 | 3.92 | 4.00 | 3.98 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 6,040,400 ÷ 1,359,700 = 4.44
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
Area Asset Turnover: Outside of the United States
Vertex Pharmaceuticals Inc.; Outside of the United States; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Revenues | 3,828,800) | 3,231,400) | 2,286,100) | 1,376,401) | 1,100,266) |
| Long-lived assets | 93,200) | 90,300) | 76,300) | 76,350) | 64,710) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 41.08 | 35.79 | 29.96 | 18.03 | 17.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 3,828,800 ÷ 93,200 = 41.08
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Outside of the United States | Outside of the United States area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
Revenues
Vertex Pharmaceuticals Inc., revenues by geographic area
US$ in thousands
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 6,040,400) | 5,699,300) | 5,288,300) | 4,829,282) | 3,062,555) |
| Outside of the United States | 3,828,800) | 3,231,400) | 2,286,100) | 1,376,401) | 1,100,266) |
| Total | 9,869,200) | 8,930,700) | 7,574,400) | 6,205,683) | 4,162,821) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Long-lived assets
Vertex Pharmaceuticals Inc., long-lived assets by geographic area
US$ in thousands
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 1,359,700) | 1,365,500) | 1,348,100) | 1,207,748) | 768,572) |
| Outside of the United States | 93,200) | 90,300) | 76,300) | 76,350) | 64,710) |
| Total | 1,452,900) | 1,455,800) | 1,424,400) | 1,284,098) | 833,282) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).